MIB1 and familial pancreatic carcinoma: To assess the association between MIB1 expression levels and pancreatic cancer clinicopathological characteristics, we evaluated MIB1 mRNA levels in the TCGA database and found that MIB1 was upregulated in 16% of pancreatic cancers (Fig. 1A).